secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0000885725-24-000025
Event type: debt
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific issues €2B in senior notes to finance Axonics acquisition
---------------------------------------------------------------------------

- AMS Europe, a Boston Scientific subsidiary, issued €750M 3.375% notes due 2029 and €1.25B 3.500% notes due 2032.
- The notes are fully and unconditionally guaranteed by Boston Scientific Corporation (BSX).
- Net proceeds of €1.98B will finance the Axonics acquisition, repay 3.45% notes due March 2024, and for general purposes.
- If the Axonics acquisition fails to close by Jan 8, 2025 (or later), a special mandatory redemption at 101% of principal applies.
- The offering closed on February 27, 2024, and net proceeds after underwriting discounts were approximately €1.980 billion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572524000025/0000885725-24-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572524000025/bsx-20240222.htm
  HTML page:      https://secwatch.observer/filing/0000885725-24-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer